Strathmann AG&Co, Hamburg, Germany Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1999
NCT00919893
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

cernilton (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Disease (Phase 3)

Pelvic Pain (Phase 3)

Prostatitis (Phase 3)

Somatoform Disorders (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1